Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis.
Xu WW, Liao L, Dai W, Zheng CC, Tan XP, He Y, Zhang QH, Huang ZH, Chen WY, Qin YR, Chen KS, He ML, Law S, Lung ML, He QY, Li B.
Xu WW, et al. Among authors: qin yr.
EBioMedicine. 2023 Jun;92:104587. doi: 10.1016/j.ebiom.2023.104587. Epub 2023 May 5.
EBioMedicine. 2023.
PMID: 37149929
Free PMC article.